Record Details

A randomized controlled clinical study to evaluate efficacy and safety of a topical Unani formulation in the management of Nār Fārsī (Eczema)

NOPR - NISCAIR Online Periodicals Repository

View Archive Info
 
 
Field Value
 
Title A randomized controlled clinical study to evaluate efficacy and safety of a topical Unani formulation in the management of Nār Fārsī (Eczema)
 
Creator Alam, K
Nawab, M
Kazmi, M H
 
Subject Dermatitis
Itching
Marham Safeda Kafoori
Nar Farsi
Unani formulation
 
Description 644-650
Nar Farsi (Eczema) is a very common skin inflammatory disorder. Its prevalence varies according to age groups and country
to country. The Unani system of medicine offers its successful management. In this study, efficacy and safety of a topical
Unani formulation was assessed and compared with a standard drug. A prospective, non inferiority, randomized, active
controlled and parallel group study was designed to study 60 participants of eczema (30 participants in each group).
The Unani formulation Marham Safeda Kafoori was studied as a test drug for 6 weeks versus allopathic medicine Clobetasol
Propionate in the study. The study findings suggested that the Unani formulation was non inferior to Clobetasol Propionate
in terms of percentage of reduction in itching, oozing, exudation, erythema, lichenification and cracking at 6 weeks of
treatment. It was observed that the difference of the mean±SD of SASSAD Score was measured as 12.83±4.76 and
14.13±5.27 in test and control groups respectively. The result was analysed as per protocol and it was found that the efficacy
of the Unani formulation was statistically significant (p
 
Date 2021-08-06T09:16:51Z
2021-08-06T09:16:51Z
2021-07
 
Type Article
 
Identifier 0975-1068 (Online); 0972-5938 (Print)
http://nopr.niscair.res.in/handle/123456789/57889
 
Language en
 
Relation Int Cl.21: A61K 9/00, A61 K 31/573, A61K 38/00, A61K 45/06
 
Publisher NIScPR-CSIR, India
 
Source IJTK Vol.20(3) [July 2021]